Please use this identifier to cite or link to this item:
Título : Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders
Autor : Palumbo, María Laura 
Moroni, Alejandro David 
Quiroga, Sofia 
Castro, María Micaela 
Burgueño, Adriana Laura 
Genaro, Ana María 
Fecha de publicación : 2021
Editorial : John Wiley & Sons Ltd British Pharmacological Society
Cita : Palumbo, M. L., et al. Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders [en línea]. Pharmacol Res Perspect. 2021, 9 (5) doi:10.1002/prp2.795. Disponible en:
Resumen : Abstract: Neurodegenerative diseases (NDD) are disorders characterized by the progressive loss of neurons affecting motor, sensory, and/or cognitive functions. The incidence of these diseases is increasing and has a great impact due to their high morbidity and mortality. Unfortunately, current therapeutic strategies only temporarily improve the patients’ quality of life but are insufficient for completely alleviating the symptoms. An interaction between the immune system and the central nervous system (CNS) is widely associated with neuronal damage in NDD. Usually, immune cell infiltration has been identified with inflammation and is considered harmful to the injured CNS. However, the immune system has a crucial role in the protection and regeneration of the injured CNS. Nowadays, there is a consensus that deregulation of immune homeostasis may represent one of the key initial steps in NDD. Dr. Michal Schwartz originally conceived the concept of “protective autoimmunity” (PA) as a well-controlled peripheral inflammatory reaction after injury, essential for neuroprotection and regeneration. Several studies suggested that immunizing with a weaker version of the neural self-antigen would generate PA without degenerative autoimmunity. The development of CNS-related peptides with immunomodulatory neuroprotective effect led to important research to evaluate their use in chronic and acute NDD. In this review, we refer to the role of PA and the potential applications of active immunization as a therapeutic option for NDD treatment. In particular, we focus on the experimental and clinical promissory findings for CNS-related peptides with beneficial immunomodulatory effects.
ISSN : 2052-1707 (en línea)
Disciplina: MEDICINA
DOI: 10.1002/prp2.795
Derechos: Acceso abierto
Appears in Collections:Artículos

Files in This Item:
File Description SizeFormat
immunomodulation-induced-central.pdf1,48 MBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Apr 27, 2024


checked on Apr 27, 2024

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons